Sites within the fourth intron of CCND1 (Cyclin D1) and the Greb1 (growth regulation by oestrogen in breast cancer 1) promoter were used as negative and positive control, respectively, for FOXA1 binding [23]. The gene discussed is FOXA1; the disease is breast carcinoma.